Published in
Lippincott, Williams & Wilkins, Journal of Hypertension, 7(29), p. 1457-1462, 2011
DOI: 10.1097/hjh.0b013e3283480db9
Links
Tools
The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
Journal article published in 2011 by
Therese Tillin 
,
Trevor Orchard,
Anders Malm,
John Fuller,
Nish Chaturvedi
,
Trevor Orchard,
Anders Malm,
John Fuller,
Nish Chaturvedi
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Recent trials question previously accepted low blood pressure targets in type 2 diabetes to reduce complication risk. We explored this question in the DIabetic REtinopathy Candesartan Trials-Protect 2 clinical trial.